Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Recurrence × Radiosurgery × Clear all

Phase

Status

Unknown 3 Completed 3 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Hepatocellular 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Neoplasms 5 Pancreatic Neoplasms 4 Lung Neoplasms 4 Prostatic Neoplasms 3 Melanoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Glioblastoma 2 Carcinoma, Renal Cell 2 Adenocarcinoma of Lung 2 Recurrence 1 Radiotherapy 1 Prostate Cancer Metastatic 1 Neoplasm, Residual 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Liver Diseases 1 Glioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1 Breast Cancer With Brain Metastasis 1 Astrocytoma 1

Interventions

Dexamethasone 8 venetoclax 4 Rituximab 4 selinexor 3 pembrolizumab 3 ibrutinib 3 Lenalidomide 3 Gemcitabine 3 Drug Therapy 3 Cytarabine 3 Bendamustine Hydrochloride 3 gilteritinib 2 fludarabine phosphate 2 carfilzomib 2 Tablets 2 Surveys and Questionnaires 2 Oxaliplatin 2 Cetuximab 2 Calcium Dobesilate 2 Busulfan 2 Bortezomib 2 Azacitidine 2 vistusertib 1 urelumab 1 tucotuzumab celmoleukin 1 trametinib 1 tocilizumab 1 tisagenlecleucel 1 thymoglobulin 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡